Poland· PL-100295660
Imatenil
A imatinib product containing imatinibum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Imatinib is registered in 4 of 19 countries.
Countries holding a registration under ATC L01XE01 (imatinib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Imatinib · ATC L01XE01
4 / 19 countries
- Belgiumprice
- Ireland
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Imatinibum
- Manufacturer
- Biofarm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- L01XE01
- ATC class
- Imatinib
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991050078
- gtin05909991050085
- gtin05909991050092
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
770 interactions on record for imatinib.
Graded by severity as the source publishes them — 114 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Imatinib · interactions on record
770 records
- 114 severe
- 518 moderate
- 23 minor
- 111 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- EliglustatA16AX10severe
- LonafarnibA16AX20severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01XE01
Imatinib, as other registers publish it.
- IrelandGlivec 100 mg film-coated tabletsNovartis Europharm Limited
- IrelandGlivec 100 mg hard capsulesNovartis Europharm Limited
- BelgiumGlivec 400 mgPI Pharma
- IrelandGlivec 400 mg film-coated tabletsNovartis Europharm Limited
- PolandImatilekPrzedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
- PolandImatilekPrzedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
- IrelandImatinib Accord 100 mg film-coated tabletsAccord Healthcare S.L.U.
- PolandImatinib AltanAltan Pharma Ltd.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eed451ae-2ed3-4780-95d8-ece24c8cd994 GET /v1/drugs/eed451ae-2ed3-4780-95d8-ece24c8cd994?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "400 mg",
"packaging": "05909991050078 ¦ Rp ¦ 83191\n10 tabl.\n05909991050085 ¦ Rp ¦ 83192\n30 tabl.\n05909991050092 ¦ Rp ¦ 83193\n90 tabl.",
"substance": "Imatinibi mesilas 477.84 mg",
"common_name": "Imatinibum",
"pl_product_id": "100295660",
"pozwolenie_nr": "20991",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about imatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.